LEXICON PHARMACEUTICALS, INC./DE 4
4 · LEXICON PHARMACEUTICALS, INC./DE · Filed Mar 3, 2014
Insider Transaction Report
Form 4
SANDS ARTHUR T
DirectorPres & CEO
Transactions
- Exercise/Conversion
Common Stock
2014-02-28+37,000→ 1,016,120 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2014-02-28−36,250→ 36,250 total→ Common Stock (36,250 underlying) - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2014-02-28−35,000→ 105,000 total→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2014-02-28+36,250→ 979,120 total - Exercise/Conversion
Common Stock
2014-02-28+35,000→ 1,051,120 total - Tax Payment
Common Stock
2014-02-28$1.92/sh−29,791$57,199→ 1,021,329 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2014-02-28−37,000→ 74,000 total→ Common Stock (37,000 underlying)
Holdings
- 817,500(indirect: By Sands Associates L.P.)
Common Stock
- 60,000(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2012 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F4]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2013 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- [F5]Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2014 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.